BlackRock still buying the Ebos dip

BlackRock still buying the Ebos dip
(Image: Getty)
Staff reporters
BlackRock continues to dip in and out of Ebos Group as the healthcare products maker trades at a cheaper price since losing the lucrative Chemist Warehouse supply deal in Australia. The international investment manager first appeared as a substantial holder of Ebos shares on June 6 with a 5% stake, or 9.6 million shares worth about $397.5m, or $41.46 per share, building up its stake over the previous three months since the healthcare products company was set to be added to the S&P/ASX 300 index.Since then, BlackRock has hovered above a...